Loading...
You are here:  Home  >  Health  >  Current News

Novartis’s LEE011 gets FDA fast track in advanced breast cancer



ZURICH (Reuters) - The U.S. Food and Drug Administration has granted priority review status for Novartis drug LEE011 (ribociclib) as a first-line treatment of postmenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in combination with letrozole, the Swiss drugmaker said on Tuesday.


Other News

Thailand finds 33 new cases of Zika, says health ministry BANGKOK (Reuters) - Thai health officials on Wednesday said 33 new Zika virus cases have been detected in the country as officials step up screening...
Surgery patients do better when hospitals are good to nurses Surgery patients do better when nurses have better working environments, according to a new study.
African study exceeds U.N. ‘test and treat’ goal for ending HIV pandemic NAIROBI (Thomson Reuters Foundation) - A U.N. goal to get seven out of 10 HIV positive people to take a test, start medication and suppress the dead...

Found news:

Loading...

You might also like...

Details on surprise Novartis heart drug success due Aug 27

Read More →